Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Revenue (Tables)

v3.24.2.u1
Note 6 - Revenue (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

Three Months Ended June 30,

 
   

2024

   

2023

 

Sales of products, net:

               

Pharmacy prescription and other revenue, net of PBM fees

  $ 10,521     $ -  

e-Commerce revenue

    3,512       2,957  

Sub total

    14,033       2,957  

Revenues from services:

               

Pharmacy 340B contract revenue

    2,956       -  
                 

Revenues, net

  $ 16,989     $ 2,957  
   

Six Months Ended June 30,

 
   

2024

   

2023

 

Sales of products, net:

               

Pharmacy prescription and other revenue, net of PBM fees

  $ 21,845     $ -  

e-Commerce revenue

    6,377       5,834  

Sub total

    28,222       5,834  

Revenues from services:

               

Pharmacy 340B contract revenue

    6,260       -  
                 

Revenues, net

  $ 34,482     $ 5,834